Fluent

Fluent Net Margin

Delisted

The Net Profit Margin of Fluent (TIUM.U.CN) as of Nov 5, 2026 is -23.38 %. In the previous year, Net Profit Margin was -42.68 % — a change of -45.21% (higher).

Net Margin

-23.38 %

YoY

-45.21%

Last updated:

Net Profit Margin of Fluent is 2023 -23.38 % . Net Profit Margin of Fluent was 2022 -42.68 % . It decreases by -45.21% higher compared to the previous year.

For Fluent, the net margin of -23.4% is up versus -229.1% a few years ago.

The Fluent Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
-229.15 USD
Jan 1, 2020
-69.90 USD
Jan 1, 2021
-29.10 USD
Jan 1, 2022
-42.68 USD
Jan 1, 2023
-23.38 USD
The Fluent Net Margin history
YEARNet MarginYoY
-23.38 %-45.21%
-42.68 %+46.68%
-29.10 %-58.38%
-69.90 %-69.50%
-229.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

Net Profit Margin of Fluent is -23.38 % in 2023.

Net Profit Margin of Fluent changed from -42.68 % to -23.38 %, representing a -45.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Fluent since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Fluent with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Fluent

All Key Metrics — Fluent